Anthropic's biolab made a discovery it's comparing to CRISPR (www.theverge.com)

Anthropic has announced a groundbreaking discovery made by its AI system, Claude, which autonomously identified a novel enzyme system resembling the mechanisms of the widely known gene-editing technology, CRISPR. This achievement marks the inaugural result from Anthropic’s newly established wet lab and serves as a critical test of the AI's scientific potential as the company aims for an upcoming public launch. The discovery involved nearly 1,000 Claude agents working for 21 hours and analyzing 210 million tokens to pinpoint an unusual pattern in a vast DNA sequence database, ultimately leading to the identification of an uncharacterized enzyme system in bacteriophages. While the implications of this discovery are still under investigation, Anthropic emphasizes the significance of showcasing Claude's capabilities and offering insights into its research endeavors to the broader scientific community. Although the company draws comparisons to CRISPR, the practical applications of the newly discovered enzyme system remain uncertain. This move aligns with a broader trend of AI companies venturing into scientific domains, where they seek to substantiate the value of their advanced models amidst growing competition in fields such as drug discovery.